GRIFOLS reported 249.86M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Alcon AG ALC:SW 773.47M 39.47M
Amadeus IT AMS:SM 377M 29.2M
Amarin AMRN:US 86.89M 3.75M
AstraZeneca AZN:LN 268.26B 35.48B
Bayer BAYN:GR 4.47B 527M
Essilor EI:FP 1.02B 101M
Fresenius FRE:GR 1.63B 154M
Fresenius Medical Care FME:GR 969M 97.76M
Galapagos GLPG:NA 71.67M 9.33M
Genmab GEN:DC 633M 181M
GlaxoSmithKline GSK:LN 195.5B 18.5B
Hikma Pharmaceutical HIK:LN 21.03B 2.1B
Merck MRK:GR 1.52B 151M
Novartis NOVN:VX 3.59B 91M
Philips PHIA:NA 1.26B 38M
William Demant Holding WDH:DC 4.9B 265M